-
1دورية أكاديمية
المؤلفون: Cummings, J.F., Polhemus, M.E., Kester, K.E., Ockenhouse, C.F., Gasser, R.A., Jr., Coyne, P., Wortmann, G., Nielsen, R.K., Schaecher, K., Holland, C.A., Krzych, U., Tornieporth, N., Soisson, L.A., Angov, E., Heppner, D.G.
المصدر: In Vaccine 30 April 2024 42(12):3066-3074
-
2دورية أكاديمية
المؤلفون: Nielsen, C.M., Vekemans, J., Lievens, M., Kester, K.E., Regules, J.A., Ockenhouse, C.F.
المصدر: In Vaccine 14 March 2018 36(12):1637-1642
-
3
المؤلفون: Diavatopoulos, D.A., Mills, K.H.G., Kester, K.E., Kampmann, B., Silerova, M., Heininger, U., Dongen, J.J.M. van, Most, R.G. van der, Huijnen, M.A., Siena, E., Mielcarek, N., Ochs, M.M., Denoel, P., Berbers, G., Buisman, A.M., Jonge, M.I. de, Fenwick, C., Gorringe, A., He, Q.S., Kelly, D., Grand, R. le, Locht, C., Mascart, F., Mertsola, J., Orfao, A., Pantaleo, G., Pollard, A.J., Preston, A., Read, R., Sebo, P., Els, C. van, Vecerek, B., Londono-Hayes, P., Groot, R. de, PERISCOPE Consortium
المساهمون: Radboud University Medical Center [Nijmegen], Trinity College Dublin, Sanofi Pasteur [Swiftwater, PN, USA] (Discovery Drive), Medical Research Council Unit The Gambia (MRC), London School of Hygiene and Tropical Medicine (LSHTM), GlaxoSmithKline Vaccines [Rixensart, Belgium], GlaxoSmithKline [Rixensart, Belgium], University of Basel (Unibas), Leiden University Medical Center (LUMC), Universiteit Leiden, GlaxoSmithKline [Siena, Italy] (GSK), Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204 (CIIL), Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Centre National de la Recherche Scientifique (CNRS), Sanofi Pasteur [Marcy-l'Étoile, France], National Institute for Public Health and the Environment [Bilthoven] (RIVM), Université de Lausanne = University of Lausanne (UNIL), Public Health England [London], University of Turku, University of Oxford, Immunologie des Maladies Virales et Autoimmunes (IMVA - U1184), Université Paris-Sud - Paris 11 (UP11)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université libre de Bruxelles (ULB), Universidad de Salamanca, University of Bath [Bath], University Hospital Southampton NHS Foundation Trust [Southampton, UK], Czech Academy of Sciences [Prague] (CAS), Mielcarek, nathalie, Centre National de la Recherche Scientifique (CNRS)-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille)-Université de Lille-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Pasteur de Lille, Réseau International des Instituts Pasteur (RIIP)-Réseau International des Instituts Pasteur (RIIP), Université de Lausanne (UNIL), University of Oxford [Oxford], Université Paris-Sud - Paris 11 (UP11)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)
المصدر: The Lancet Infectious Diseases
The Lancet Infectious Diseases, 2019, 19 (5), pp.e179-e186. ⟨10.1016/s1473-3099(18)30646-7⟩
Lancet Infectious Diseases, 19, 5, pp. E179-E186
The Lancet Infectious Diseases, New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001-, 2019, 19 (5), pp.e179-e186. ⟨10.1016/s1473-3099(18)30646-7⟩
Lancet Infectious Diseases, 19, E179-E186
The Lancet Infectious Diseases, 19(5), E179-E186. ELSEVIER SCI LTDمصطلحات موضوعية: 0301 basic medicine, Protective immunity, Economic growth, medicine.medical_specialty, Whooping Cough, International Cooperation, [SDV]Life Sciences [q-bio], Drug Evaluation, Preclinical, lnfectious Diseases and Global Health Radboud Institute for Molecular Life Sciences [Radboudumc 4], Bordetella pertussis, 03 medical and health sciences, Immunogenicity, Vaccine, 0302 clinical medicine, All institutes and research themes of the Radboud University Medical Center, [SDV.IMM.VAC] Life Sciences [q-bio]/Immunology/Vaccinology, Age groups, medicine, Animals, Humans, 030212 general & internal medicine, Pertussis Vaccine, Licensure, Immunity, Cellular, Incidence, Public health, Vaccination, Metabolic Disorders Radboud Institute for Molecular Life Sciences [Radboudumc 6], Infant mortality, Immunity, Humoral, 3. Good health, Europe, [SDV] Life Sciences [q-bio], 030104 developmental biology, Infectious Diseases, Bibliometrics, Carrier State, Business, [SDV.IMM.VAC]Life Sciences [q-bio]/Immunology/Vaccinology, Biomarkers
وصف الملف: application/pdf
-
4دورية أكاديمية
المؤلفون: Keitel, W.A *, Kester, K.E, Atmar, R.L, White, A.C, Jr, Bond, N.H, Holland, C.A, Krzych, U, Palmer, D.R, Egan, A, Diggs, C, Ballou, W.R, Hall, B.F, Kaslow, D
المصدر: In Vaccine 1999 18(5):531-539
-
5دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
6دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
7دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
8دورية أكاديمية
المؤلفون: Ballou, W.R., Kester, K.E., Heppner, D.G.
المصدر: Chemical Immunology & Allergy; 2002, Vol. 80, p253-261, 9p
-
9دورية
المؤلفون: Berman, J.D., Nielsen, R., Chulay, J.D., Dowler, M., Kain, K.C., Kester, K.E., Williams, J., Whelen, A.C., Shmuklarsky, M.J.
المصدر: Transactions of the Royal Society of Tropical Medicine & Hygiene; July 2001, Vol. 95 Issue: 4 p429-432, 4p
-
10دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.